- Home
- GCTK vs PTIX Comparison
GCTK vs PTIX Comparison
Compare GCTK & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTK
- PTIX
- Stock Information
- Founded
- GCTK 2001
- PTIX 1994
- Country
- GCTK United States
- PTIX United States
- Employees
- GCTK N/A
- PTIX N/A
- Industry
- GCTK Medical/Dental Instruments
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- GCTK Health Care
- PTIX Health Care
- Exchange
- GCTK Nasdaq
- PTIX Nasdaq
- Market Cap
- GCTK 3.3M
- PTIX 2.8M
- IPO Year
- GCTK N/A
- PTIX 2016
- Fundamental
- Price
- GCTK $5.72
- PTIX $2.78
- Analyst Decision
- GCTK
- PTIX
- Analyst Count
- GCTK 0
- PTIX 0
- Target Price
- GCTK N/A
- PTIX N/A
- AVG Volume (30 Days)
- GCTK 81.7K
- PTIX 104.7K
- Earning Date
- GCTK 08-14-2025
- PTIX 08-22-2025
- Dividend Yield
- GCTK N/A
- PTIX N/A
- EPS Growth
- GCTK N/A
- PTIX N/A
- EPS
- GCTK N/A
- PTIX N/A
- Revenue
- GCTK N/A
- PTIX N/A
- Revenue This Year
- GCTK N/A
- PTIX N/A
- Revenue Next Year
- GCTK N/A
- PTIX N/A
- P/E Ratio
- GCTK N/A
- PTIX N/A
- Revenue Growth
- GCTK N/A
- PTIX N/A
- 52 Week Low
- GCTK $5.11
- PTIX $2.35
- 52 Week High
- GCTK $3,756.00
- PTIX $15.54
- Technical
- Relative Strength Index (RSI)
- GCTK 42.45
- PTIX 41.42
- Support Level
- GCTK $5.64
- PTIX $2.60
- Resistance Level
- GCTK $5.98
- PTIX $3.24
- Average True Range (ATR)
- GCTK 0.37
- PTIX 0.27
- MACD
- GCTK -0.03
- PTIX 0.02
- Stochastic Oscillator
- GCTK 11.65
- PTIX 27.69
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.